171 related articles for article (PubMed ID: 37181780)
21. Differentiation between genetic mutations of breast cancer by breath volatolomics.
Barash O; Zhang W; Halpern JM; Hua QL; Pan YY; Kayal H; Khoury K; Liu H; Davies MP; Haick H
Oncotarget; 2015 Dec; 6(42):44864-76. PubMed ID: 26540569
[TBL] [Abstract][Full Text] [Related]
22. Development of a headspace-solid phase microextraction gas chromatography-high resolution mass spectrometry method for analyzing volatile organic compounds in urine: Application in breast cancer biomarker discovery.
Li X; Wen X; Luo Z; Tian Y; Qian C; Zhang J; Ling R; Duan Y
Clin Chim Acta; 2023 Feb; 540():117236. PubMed ID: 36716910
[TBL] [Abstract][Full Text] [Related]
23. Non-Invasive Staging of In Vitro Mice Embryos by Means of Volatolomics.
Raya YSA; Hershkovitz-Pollak Y; Ionescu R; Haick H
ACS Sens; 2022 Jul; 7(7):2006-2011. PubMed ID: 35709541
[TBL] [Abstract][Full Text] [Related]
24. Dysregulation of metabolic-associated pathways in muscle of breast cancer patients: preclinical evaluation of interleukin-15 targeting fatigue.
Bohlen J; McLaughlin SL; Hazard-Jenkins H; Infante AM; Montgomery C; Davis M; Pistilli EE
J Cachexia Sarcopenia Muscle; 2018 Aug; 9(4):701-714. PubMed ID: 29582584
[TBL] [Abstract][Full Text] [Related]
25. Gas chromatography-mass spectrometry based untargeted volatolomics for smoked seafood classification.
Lacalle-Bergeron L; Portolés T; Sales C; Carmen Corell M; Domínguez F; Beltrán J; Vicente Sancho J; Hernández F
Food Res Int; 2020 Nov; 137():109698. PubMed ID: 33233272
[TBL] [Abstract][Full Text] [Related]
26. Volatolomics of breath as an emerging frontier in pulmonary arterial hypertension.
Nakhleh MK; Haick H; Humbert M; Cohen-Kaminsky S
Eur Respir J; 2017 Feb; 49(2):. PubMed ID: 28232412
[TBL] [Abstract][Full Text] [Related]
27. Targeted volatolomics of human monocytes: Comparison of 2D-GC/TOF-MS and 1D-GC/Orbitrap-MS methods.
Zemánková K; Pavelicová K; Pompeiano A; Mravcová L; Černý M; Bendíčková K; Hortová Kohoutková M; Dryahina K; Vaculovičová M; Frič J; Vaníčková L
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Nov; 1184():122975. PubMed ID: 34655893
[TBL] [Abstract][Full Text] [Related]
28. Combination of Targeted Therapies for Colorectal Cancer Treatment.
Péraudeau E; Renoux B; Emambux S; Poinot P; Châtre R; Thoreau F; Riss Yaw B; Tougeron D; Clarhaut J; Papot S
Mol Pharm; 2023 Sep; 20(9):4537-4545. PubMed ID: 37579031
[TBL] [Abstract][Full Text] [Related]
29. A β-glucuronidase-responsive albumin-binding prodrug for potential selective kinase inhibitor-based cancer chemotherapy.
Compain G; Oumata N; Clarhaut J; Péraudeau E; Renoux B; Galons H; Papot S
Eur J Med Chem; 2018 Oct; 158():1-6. PubMed ID: 30199702
[TBL] [Abstract][Full Text] [Related]
30. Recent Advances in Sensing Materials Targeting Clinical Volatile Organic Compound (VOC) Biomarkers: A Review.
Pathak AK; Swargiary K; Kongsawang N; Jitpratak P; Ajchareeyasoontorn N; Udomkittivorakul J; Viphavakit C
Biosensors (Basel); 2023 Jan; 13(1):. PubMed ID: 36671949
[TBL] [Abstract][Full Text] [Related]
31. The Human Skin Volatolome: A Systematic Review of Untargeted Mass Spectrometry Analysis.
Mitra A; Choi S; Boshier PR; Razumovskaya-Hough A; Belluomo I; Spanel P; Hanna GB
Metabolites; 2022 Sep; 12(9):. PubMed ID: 36144228
[TBL] [Abstract][Full Text] [Related]
32. Activated platelets in the tumor microenvironment for targeting of antibody-drug conjugates to tumors and metastases.
Yap ML; McFadyen JD; Wang X; Ziegler M; Chen YC; Willcox A; Nowell CJ; Scott AM; Sloan EK; Hogarth PM; Pietersz GA; Peter K
Theranostics; 2019; 9(4):1154-1169. PubMed ID: 30867822
[No Abstract] [Full Text] [Related]
33. Inhibitory prodrug mechanism for cysteine cathepsin-targeted self-controlled drug release.
van Dalen FJ; Verdoes M
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):2566-2573. PubMed ID: 36120947
[TBL] [Abstract][Full Text] [Related]
34. Methods to Detect Volatile Organic Compounds for Breath Biopsy Using Solid-Phase Microextraction and Gas Chromatography-Mass Spectrometry.
Schulz E; Woollam M; Grocki P; Davis MD; Agarwal M
Molecules; 2023 Jun; 28(11):. PubMed ID: 37299010
[TBL] [Abstract][Full Text] [Related]
35. Development of a fluorescent probe library enabling efficient screening of tumour-imaging probes based on discovery of biomarker enzymatic activities.
Kuriki Y; Yoshioka T; Kamiya M; Komatsu T; Takamaru H; Fujita K; Iwaki H; Nanjo A; Akagi Y; Takeshita K; Hino H; Hino R; Kojima R; Ueno T; Hanaoka K; Abe S; Saito Y; Nakajima J; Urano Y
Chem Sci; 2022 Apr; 13(16):4474-4481. PubMed ID: 35656140
[TBL] [Abstract][Full Text] [Related]
36. In vivo synthesis of triple-loaded albumin conjugate for efficient targeted cancer chemotherapy.
Châtre R; Lange J; Péraudeau E; Poinot P; Lerondel S; Le Pape A; Clarhaut J; Renoux B; Papot S
J Control Release; 2020 Nov; 327():19-25. PubMed ID: 32777236
[TBL] [Abstract][Full Text] [Related]
37. Targeted breath analysis: exogenous volatile organic compounds (EVOC) as metabolic pathway-specific probes.
Gaude E; Nakhleh MK; Patassini S; Boschmans J; Allsworth M; Boyle B; van der Schee MP
J Breath Res; 2019 May; 13(3):032001. PubMed ID: 30965287
[TBL] [Abstract][Full Text] [Related]
38. Conditionally activated affibody-based prodrug targeting EGFR demonstrates improved tumour selectivity.
Dahlsson Leitao C; Mestre Borras A; Xu T; Oroujeni M; Liu Y; Westerberg C; Clinton J; Tolmachev V; Orlova A; Ståhl S; Vorobyeva A; Löfblom J
J Control Release; 2023 May; 357():185-195. PubMed ID: 36990160
[TBL] [Abstract][Full Text] [Related]
39. LC-MS/MS Based Volatile Organic Compound Biomarkers Analysis for Early Detection of Lung Cancer.
Sani SN; Zhou W; Ismail BB; Zhang Y; Chen Z; Zhang B; Bao C; Zhang H; Wang X
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831528
[TBL] [Abstract][Full Text] [Related]
40. Exhaled VOCs can discriminate subjects with COVID-19 from healthy controls.
Woollam M; Angarita-Rivera P; Siegel AP; Kalra V; Kapoor R; Agarwal M
J Breath Res; 2022 May; 16(3):. PubMed ID: 35453137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
